United Bank (Georgia)’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-1,423
Closed -$218K – 114
2024
Q4
$218K Sell
1,423
-2,213
-61% -$373K 0.09% 103
2024
Q3
$705K Sell
3,636
-126
-3% -$26.4K 0.33% 71
2024
Q2
$872K Buy
3,762
+289
+8% +$62.8K 0.44% 62
2024
Q1
$749K Buy
3,473
+516
+17% +$121K 0.38% 67
2023
Q4
$765K Sell
2,957
-92
-3% -$22.6K 0.42% 65
2023
Q3
$784K Buy
3,049
+577
+23% +$154K 0.47% 62
2023
Q2
$704K Buy
2,472
+341
+16% +$102K 0.4% 72
2023
Q1
$592K Buy
+2,131
New +$590K 0.35% 73
2020
Q1
– Sell
-2,335
Closed -$693K – 72
2019
Q4
$693K Sell
2,335
-479
-17% -$133K 0.47% 62
2019
Q3
$655K Buy
2,814
+5
+0.2% +$1.16K 0.49% 60
2019
Q2
$657K Buy
2,809
+818
+41% +$189K 0.51% 57
2019
Q1
$471K Sell
1,991
-369
-16% -$116K 0.38% 61
2018
Q4
$710K Sell
2,360
-430
-15% -$137K 0.65% 51
2018
Q3
$986K Sell
2,790
-343
-11% -$118K 0.78% 50
2018
Q2
$909K Buy
3,133
+409
+15% +$115K 0.78% 50
2018
Q1
$746K Sell
2,724
-306
-10% -$95K 0.68% 53
2017
Q4
$965K Sell
3,030
-52
-2% -$16.7K 0.83% 51
2017
Q3
$965K Sell
3,082
-110
-3% -$32.6K 0.9% 50
2017
Q2
$866K Buy
3,192
+357
+13% +$94.4K 0.8% 52
2017
Q1
$775K Buy
2,835
+163
+6% +$46.1K 0.74% 54
2016
Q4
$758K Buy
+2,672
New +$792K 0.77% 55

Other funds holding BIIB

United Bank (Georgia)'s BIIB Position: Q1 2025 in Review

United Bank (Georgia) sold out of Biogen (BIIB) in Q1 2025, closing a stake of 1,423 shares — an estimated $218K sold.

United Bank (Georgia) first reported a position in BIIB in Q4 2016 and held it in 21 quarters. The position peaked at $986K in Q3 2018. 883 funds tracked by Wall St. Rank hold BIIB as of Q1 2025.

  • United Bank (Georgia) reported no remaining Biogen position as of Q1 2025 after selling out during the quarter.
  • United Bank (Georgia) sold 1,423 Biogen shares in Q1 2025, an estimated $218K.
  • United Bank (Georgia) first reported a position in Biogen in Q4 2016 and held it in 21 quarters.
  • United Bank (Georgia)'s Biogen position peaked at $986K in Q3 2018.
  • 883 funds tracked by Wall St. Rank held Biogen as of Q1 2025.

Based on United Bank (Georgia)'s 13F filing for Q1 2025, filed 6 May 2025.